Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

被引：0
|
作者：
Zahr, Rima S. [1 ]
Rashkin, Sara R. [2 ]
Ruiz, Maria Armila [3 ]
Elsherif, Laila [4 ]
Ren, Guohui [3 ]
Salas, Guadalupe [3 ]
Ataga, Kenneth I. [4 ]
Gordeuk, Victor R. [3 ]
Lebensburger, Jeffrey [5 ]
Zhang, Xu [3 ]
Saraf, Santosh L. [3 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Div Pediat Nephrol & Hypertens, Memphis, TN 38152 USA
[2] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA
[3] Univ Illinois, Div Hematol & Oncol, Chicago, IL 60607 USA
[4] Univ Tennesse, Ctr Sickle Cell Dis, Hlth Sci Ctr, Memphis, TN USA
[5] Univ Alabama Birmingham, Div Pediat Hematol & Oncol, Birmingham, AL USA
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 10期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.3324/haematol.2023.284920
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3368 / 3372
页数：5
相关论文
共 50 条
  • [31] Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
    Ahmed, Reem M.
    Khalil, Mona A.
    Ibrahim, Amal H.
    Eid, Hanaa M.
    Abdelbasset, Walid Kamal
    Soliman, Gaber S.
    MEDICINE, 2019, 98 (38)
  • [32] The urokinase plasminogen activator and its receptor - Role in cell growth and apoptosis
    Alfano, D
    Franco, P
    Vocca, I
    Gambi, N
    Pisa, V
    Mancini, A
    Caputi, M
    Carriero, MV
    Iaccarino, I
    Stoppelli, MP
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (02) : 205 - 211
  • [33] Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque
    Edsfeldt, Andreas
    Nitulescu, Mihaela
    Grufman, Helena
    Gronberg, Caitriona
    Persson, Ana
    Nilsson, Marie
    Persson, Margaretha
    Bjorkbacka, Harry
    Goncalves, Isabel
    STROKE, 2012, 43 (12) : 3305 - 3312
  • [34] Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis
    Drueke, Tilman B.
    Massy, Ziad A.
    KIDNEY INTERNATIONAL, 2023, 103 (03) : 451 - 454
  • [35] Soluble urokinase plasminogen activator receptor in blood transfusion components
    Riisbro, R
    Brünner, N
    Christensen, IJ
    Nielsen, HJ
    TRANSFUSION MEDICINE, 2004, 14 (04) : 305 - 312
  • [36] Association of blood levels of urokinase plasminogen activator and its soluble receptor with prostate cancer presence, invasion, progression, and metastasis
    Shariat, S.
    McConnell, J.
    Park, S.
    Wheeler, T.
    Slawin, K.
    Roehrborn, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 249 - 249
  • [37] Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism
    Engstrom, Gunnar
    Zoller, Bengt
    Svensson, Peter J.
    Melander, Olle
    Persson, Margaretha
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (03) : 657 - 662
  • [38] Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality
    Tornkovist, Peter B. S.
    Haupt, Thomas H.
    Rasmussen, Line J. H.
    Ladelundl, Steen
    Toft, Ulla
    Pisinger, Charlotta
    Eugen-Olsen, Jesper
    BRITISH JOURNAL OF NUTRITION, 2019, 121 (06) : 699 - 708
  • [39] Soluble urokinase plasminogen activator receptor is associated with cardiovascular calcification in peritoneal dialysis patients
    Jichao Guan
    Shuwen Gong
    Qiuli He
    Xiaoling Wang
    Shuijuan Shen
    Xiujuan Wu
    Juanping Shan
    Tujian Gong
    Yanru Yang
    Haiying Xie
    International Urology and Nephrology, 2024, 56 : 191 - 198
  • [40] Urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) serum level in patients with malignant lymphomas
    Hus, I
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    Chrapko, M
    Hus, M
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 141 - 144
12345